Edesa Biotech Stock Soars 54%: What’s Driving the ARDS Drug Rally Now
Edesa Biotech Inc. surged 53.9% to finish Monday at $11.17 on Nasdaq, after opening the day at $7.38 and reaching as high as $11.87. Trading volume spiked close to 9.0 million shares—a notable swing for the small clinical-stage biotech, especially considering its most recent company news release was nearly a month old.